T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,205.00
+75.00 (2.40%)
At close: Mar 6, 2026
29.06%
Market Cap 152.46B
Revenue (ttm) 20.67B
Net Income (ttm) -9.61B
Shares Out 47.57M
EPS (ttm) -371.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 499,023
Average Volume 693,035
Open 3,110.00
Previous Close 3,130.00
Day's Range 2,980.00 - 3,245.00
52-Week Range 1,127.00 - 4,925.00
Beta 0.49
RSI 48.69
Earnings Date Mar 17, 2026

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.